SCHEMBL9941201

SCHEMBL9941201

CCNc1nccn2c(-c3ccc(C(N)=O)c(C4CC4)c3)cnc12

nearest known ligand 0.54

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TTK P33981 19/20 0.54
MAPKAPK5 Q8IW41 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9938292 0.90 TTK (0.55) TTKMAPKAPK5
SCHEMBL9941127 0.88 TTK (0.53) TTKMAPKAPK5
SCHEMBL9940873 0.87 TTK (0.51) TTKMAPKAPK5
SCHEMBL9941237 0.85 TTK (0.49) TTKMAPKAPK5
SCHEMBL9940914 0.85 TTK (0.51) TTKMAPKAPK5
SCHEMBL9940987 0.84 TTK (0.49) TTKMAPKAPK5
SCHEMBL9940982 0.84 MAPKAPK5 (0.51) TTKMAPKAPK5
SCHEMBL9941138 0.83 TTK (0.57) TTKMAPKAPK5
SCHEMBL9941053 0.82 MAPKAPK5 (0.50) TTKMAPKAPK5
SCHEMBL9941198 0.82 TTK (0.47) TTKMAPKAPK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2651948-A1 IMIDAZOPYRAZINES FOR USE AS MPS-1 AND TKK INHIBITORS IN THE TREATMENT HYPERPROLIFERATIVE DISORDERS Bayer Intellectual Property GmbH (DE) 2013-10-23 EP claimed
WO-2012080229-A1 IMIDAZOPYRAZINES FOR USE AS MPS-1 AND TKK INHIBITORS IN THE TREATMENT HYPERPROLIFERATIVE DISORDERS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-06-21 WO claimed